| FME Stock | | | 42.52 0.55 1.31% |
CEO
Helen Giza is Chief CEO of Fresenius Medical Care
| Age | 55 |
| Phone | 49 6172 608 2522 |
| Web | https://www.freseniusmedicalcare.com |
Fresenius Medical Management Efficiency
The company has return on total asset
(ROA) of
0.0277 % which means that it generated a profit of $0.0277 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
0.0608 %, meaning that it generated $0.0608 on every $100 dollars invested by stockholders. Fresenius Medical's management efficiency ratios could be used to measure how well Fresenius Medical manages its routine affairs as well as how well it operates its assets and liabilities.
Fresenius Medical Care has accumulated 7.17
B in total debt. Debt can assist Fresenius Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Fresenius Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Fresenius Medical Care sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Fresenius to invest in growth at high rates of return. When we think about Fresenius Medical's use of debt, we should always consider it together with cash and equity.
Similar Executives
Fresenius Medical Care (FME) is traded on XETRA Stock Exchange in Germany and employs 128,044 people.
Management Performance
Fresenius Medical Care Leadership Team
Elected by the shareholders, the Fresenius Medical's board of directors comprises two types of representatives: Fresenius Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Fresenius. The board's role is to monitor Fresenius Medical's management team and ensure that shareholders' interests are well served. Fresenius Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Fresenius Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Dominik Heger, Strategic Relations | |
| Helen Giza, Chief CEO | |
| Roberto Fuste, Ex Strategy | |
| William Valle, Management AG | |
| Nwamaka MD, Head Operations | |
| Katarzyna MazurHofsab, Management AG | |
| Borries Muller, VP Communications | |
| Joachim Weith, Sr Affairs | |
| Robert Powell, Member AG | |
| Franklin FACP, Global AG | |
Fresenius Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Fresenius Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Fresenius Stock Analysis
When running Fresenius Medical's price analysis, check to
measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to
predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.